Patents by Inventor Jeffrey R. Gingrich

Jeffrey R. Gingrich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for ameliorating pain by modification of NMDA receptors through inhibition of SRC
    Patent number: 8859500
    Abstract: The present invention provides a method for ameliorating inflammatory and/or neuropathic pain in a subject by modifying the activity of N-methyl-D-aspartate (NMDA) receptors in cells of the subject by inhibition of the interaction of the unique domain of the tyrosine kinase Src enzyme and the NMDA receptor complex.
    Type: Grant
    Filed: March 21, 2012
    Date of Patent: October 14, 2014
    Assignee: The Hospital For Sick Children
    Inventors: Michael W. Salter, Jeffrey R. Gingrich
  • METHOD FOR AMELIORATING PAIN BY MODIFICATION OF NMDA RECEPTORS THROUGH INHIBITION OF SRC
    Publication number: 20130288974
    Abstract: The present invention provides a method for ameliorating inflammatory and/or neuropathic pain in a subject by modifying the activity of N-methyl-D-aspartate (NMDA) receptors in cells of the subject by inhibition of the interaction of the unique domain of the tyrosine kinase Src enzyme and the NMDA receptor complex.
    Type: Application
    Filed: March 21, 2012
    Publication date: October 31, 2013
    Applicant: The Hospital For Sick Children
    Inventors: Michael W. Salter, Jeffrey R. Gingrich
  • Method for ameliorating pain by modification of NMDA receptors through inhibition of Src
    Patent number: 8158749
    Abstract: The present invention provides a method for ameliorating inflammatory and/or neuropathic pain in a subject by modifying the activity of N-methyl-D-aspartate (NMDA) receptors in cells of the subject by inhibition of the interaction of the unique domain of the tyrosine kinase Src enzyme and the NMDA receptor complex.
    Type: Grant
    Filed: June 21, 2011
    Date of Patent: April 17, 2012
    Assignee: The Hospital for Sick Children
    Inventors: Michael W. Salter, Jeffrey R. Gingrich
  • METHOD FOR AMELIORATING PAIN BY MODIFICATION OF NMDA RECEPTORS THROUGH INHIBITION OF SRC
    Publication number: 20120029168
    Abstract: The present invention provides a method for ameliorating inflammatory and/or neuropathic pain in a subject by modifying the activity of N-methyl-D-aspartate (NMDA) receptors in cells of the subject by inhibition of the interaction of the unique domain of the tyrosine kinase Src enzyme and the NMDA receptor complex.
    Type: Application
    Filed: June 21, 2011
    Publication date: February 2, 2012
    Applicant: THE HOSPITAL FOR SICK CHILDREN
    Inventors: MICHAEL W. SALTER, JEFFREY R. GINGRICH
  • Method for ameliorating pain by modification of NMDA receptors through inhibition of Src
    Patent number: 8003609
    Abstract: The present invention provides a method for ameliorating inflammatory and/or neuropathic pain in a subject by modifying the activity of N-methyl-D-aspartate (NMDA) receptors in cells of the subject by inhibition of the interaction of the unique domain of the tyrosine kinase Src enzyme and the NMDA receptor complex.
    Type: Grant
    Filed: August 29, 2006
    Date of Patent: August 23, 2011
    Assignee: The Hospital for Sick Children
    Inventors: Michael W. Salter, Jeffrey R. Gingrich
  • Method for modification of NMDA receptors through inhibition of Src
    Patent number: 7425540
    Abstract: The present invention provides a method for modifying the activity of NMDA (N-methyl-D-aspartate)receptors in cells by inhibition of the interaction of the unique domain of the tyrosine kinase Src enzyme and the NMDA receptor complex.
    Type: Grant
    Filed: March 30, 2004
    Date of Patent: September 16, 2008
    Assignee: The Hospital for Sick Children
    Inventors: Michael W. Salter, Jeffrey R. Gingrich